August 17, 2025Deleted Journal

The potential of short-chain fatty acids-producing probiotics as a treatment for liver disease: a systematic review

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Systematic review finds SCFA-producing probiotics improve liver function in animal models, indicating therapeutic promise.

SCFA-producing probiotics improved liver function, enhancing gut health and microbial balance.
Animal studies showed significant reductions in liver enzymes ALT and AST, alongside improved intestinal integrity.
Analysis employed PRISMA 2020 methodology and evaluated 14 preclinical studies on probiotics in liver disease.
Findings suggest potential adjunctive therapies for liver disease, but further studies on efficacy and safety are warranted.

Azizah et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark